These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2092640)

  • 1. [Ciprofloxacin in the treatment of infections in oncology patients].
    Dronova OM
    Antibiot Khimioter; 1990 Nov; 35(11):51-4. PubMed ID: 2092640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ; Plouffe JF; Russell JA
    Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
    Blatun LA; Iakovlev VP; Svetukhin AM; Puchkova LS; Izotova GN
    Antibiot Khimioter; 1996; 41(9):73-6. PubMed ID: 9005792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoroquinolones--a new and important group of antimicrobial agents].
    Sander J
    Tidsskr Nor Laegeforen; 1992 Jan; 112(3):346-9. PubMed ID: 1553674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the treatment with oral ciprofloxacin: experience with 24 patients].
    Parras F; Torroba L; Buzón L; Martínez-Beltrán J; Loza E; Baquero F
    Enferm Infecc Microbiol Clin; 1989 May; 7(5):261-5. PubMed ID: 2490722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ciprofloxacin for treatment of severe infections.
    Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
    Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
    Sanders WE
    Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ciprofloxacin therapy for infections in cancer patients.
    Haron E; Rolston KV; Cunningham C; Holmes F; Umsawasdi T; Bodey GP
    J Antimicrob Chemother; 1989 Dec; 24(6):955-62. PubMed ID: 2516086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ofloxacin vs ciprofloxacin: a comparison.
    Nicolau D; Quintiliani R; Nightingale CH
    Conn Med; 1992 May; 56(5):261-3. PubMed ID: 1611900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imipenem-cilastatin in the treatment of suppurative inflammatory complications in the cancer clinic].
    Dronova OM; Dmitrieva NV; Petukhova IN
    Antibiot Khimioter; 1994; 39(2-3):41-4. PubMed ID: 7979794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.
    Neu HC; Davidson S; Briones F
    Am J Med; 1989 Nov; 87(5A):209S-212S. PubMed ID: 2511758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin in multi-resistant infections in childhood: an audit.
    Khan DM; Bhutta ZA
    J Pak Med Assoc; 1995 Jun; 45(6):147-50. PubMed ID: 7474287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activity of ciprofloxacin and netilmicin compared to various antibiotics in Lome, Togo].
    Dagnra AY; Prince-David M; Hounkpati A
    Sante; 2001; 11(1):63-6. PubMed ID: 11313234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous ciprofloxacin for the treatment of severe infections.
    Santini C; Baiocchi P; Venditti M; Gelfusa V; Tarasi A; Brandimarte C; Serra P
    J Chemother; 1991 Apr; 3(2):121-5. PubMed ID: 1875231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.